MoonLake Immunotherapeutics (MLTX) Cash per Single Share

MoonLake Immunotherapeutics - graphic logo of issuer MLTX

The cash per share history on the GURU.Markets terminal chart demonstrates a lack of regular income, as MoonLake Immunotherapeutics (MLTX) relies on external investments, while the 5.88 value shows the current liquidity level. Risks are mitigated by developing a single drug for various pathologies, and the global humanitarian status of the research minimizes the impact of geopolitical factors.

Cash Funds per Share: MoonLake Immunotherapeutics (MLTX) for 04/28/2023 - 11/20/2026

Analytical breakdowns for MoonLake Immunotherapeutics

- market value and analyst target forecast:
- cash availability and cash flow indicators:
Comprehensive company analysis:MoonLake Pharma
Original product of MoonLake Immunotherapeutics AG

Analyzing the cash cushion per share allows for an assessment of the financial stability of MoonLake Immunotherapeutics (MLTX) as a biotech issuer with a diversified clinical trial portfolio. This indicator calculates the volume of liquid reserves per security, enabling investors to differentiate strategic development investments from operational deficits and determine the real value of the fundamental support for the share price.

Key competitors